Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$7,175,238
-$1,301,440 QoQ
Shares Held
297,975
-1.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#499
of 2,821 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KESTRA PRIVATE WEALTH SERVICES, LLC holds $235,896,515 across 13 Drug Manufacturers - General names. PFE ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
56,415 | $67,665,849 | |
| 2 | ABBV |
AbbVie Inc.
|
180,625 | $45,452,475 | |
| 3 | MRK |
Merck & Co., Inc.
|
256,709 | $32,987,106 | |
| 4 | JNJ |
Johnson & Johnson
|
126,054 | $32,013,934 | |
| 5 | AMGN |
Amgen Inc
|
79,392 | $28,749,431 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
151,030 | $8,702,348 | |
| 7 | PFE |
Pfizer Inc
This page
|
297,975 | $7,175,238 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
31,538 | $3,984,510 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,175,238 | 297,975 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,476,678 | 301,876 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $8,260,350 | 331,741 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $9,187,527 | 360,578 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,358,948 | 303,587 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,596,830 | 299,796 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,859,857 | 296,263 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $8,340,334 | 288,194 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,991,317 | 321,348 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,682,836 | 312,895 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $8,354,973 | 290,204 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $9,350,025 | 281,882 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,516,699 | 259,452 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $8,956,334 | 219,518 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,721,201 | 209,235 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $8,105,139 | 185,218 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,793,556 | 186,793 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,942,739 | 192,056 | Shares | Sole | 2022-07-21 | |
| 2021-12-31 | $11,763,350 | 199,210 | Shares | Sole | 2022-07-21 | |
| 2021-09-30 | $7,882,184 | 183,264 | Shares | Sole | 2022-07-26 | |
| 2021-06-30 | $7,116,037 | 181,717 | Shares | Sole | 2022-07-27 | |
| 2021-03-31 | $6,671,537 | 184,144 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $6,401,369 | 173,903 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $6,004,737 | 163,617 | Shares | Sole | 2022-07-28 | |
| No filing history on record for this holder in this stock. | ||||||